Medical Student Research Forum Posters

Hypertension (HTN) affects ~1.4 billion people worldwide and is a leading cause of cardiovascular disease (CVD) and earlydeath. Recent guidelines recommend lower blood pressure (BP) targets, but the optimal BP target for individuals with low diastolic BP (DBP) remains controversial because of the Jcurve phenomenon:  Low DBP is associated with increased CVD risk and death, thought to be due to reduced coronary perfusion indiastole. High sensitivity cardiac troponin T (hs-cTnT), a biomarker of subclinical myocardial injury, may be able to identify individualswith low DBP at-risk of harm from additional BP lowering. However, there are no data from randomized trials on whether lower BP targets have similar CVD and mortality benefits inindividuals with low DBP and elevated hs-cTnT.